ATNM
AMEX · Biotechnology
Actinium Pharmaceuticals Inc
$1.18
-0.02 (-1.67%)
Open$1.18
Previous Close$1.20
Day High$1.20
Day Low$1.17
52W High$1.74
52W Low$0.74
Volume—
Avg Volume141.4K
Market Cap37.42M
P/E Ratio3.31
EPS$0.36
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+2,960.2% upside
Current
$1.18
$1.18
Target
$36.11
$36.11
$23.47
$36.11 avg
$39.96
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 90.4K | 203.8K | 4.99M |
| Net Income | -33,870,209 | -68,702,249 | -1,193,914 |
| Profit Margin | -37,652.2% | -35,769.6% | -23.9% |
| EBITDA | -36,055,887 | -77,198,766 | -1,575,968 |
| Free Cash Flow | — | — | -691,464 |
| Rev Growth | -55.6% | -55.6% | +20.9% |
| Debt/Equity | 0.00 | 0.00 | 0.67 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |